Abstract
The activation of sphingomyelinases leading to the generation of ceramide has been implicated in various apoptotic pathways. However, the role of ceramide as an essential death mediator remains highly controversial. In the present study, we investigated the functional relevance of ceramide in a genetic model by using primary cells from a Farber disease patient. These cells accumulate ceramide as the result of an inherited deficiency of acidic ceramidase. We demonstrate that Farber disease lymphocytes and fibroblasts underwent apoptosis induced by various stress stimuli, including staurosporine, anticancer drugs and γ-irradiation, equally as normal control cells. In addition, caspase activation by these proapoptotic agents occurred rather similarly in Farber disease and control fibroblasts. Interestingly, Farber disease lymphoid cells underwent apoptosis induced by the CD95 death receptor more rapidly than control cells. Our data therefore suggest that ceramide does not play an essential role as a second messenger in stress-induced apoptosis. However, in accordance with a role in lipid-rich microdomains, ceramide by altering membrane composition may function as an amplifier in CD95-mediated apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bezombes C, Segui B, Cuvillier O, Bruno AP, Uro-Coste E, Gouaze V, Andrieu-Abadie N, Carpentier S, Laurent G, Salvayre R, Jaffrezou JP, Levade T . 2001 FASEB J. 15: 297–299
Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J . 1998 J. Biol. Chem. 273: 7560–7565
Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R . 1995 Cell 82: 405–414
Chatelut M, Feunteun J, Harzer K, Fensom AH, Basile JP, Salvayre R, Levade T . 1996 Clin. Chim. Acta 245: 61–71
Chatelut M, Leruth M, Harzer K, Dagan A, Marchesini S, Gatt S, Salvayre R, Courtoy P, Levade T . 1998 FEBS Lett. 426: 102–106
Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R . 1994 J. Exp. Med. 180: 1547–1552
Cremesti A, Paris F, Grassme H, Holler N, Tschopp J, Fuks Z, Gulbins E, Kolesnick R . 2001 J. Biol. Chem. 276: 23954–23961
De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, Zeuner A, Rippo MR, Testi R . 1997 Science 277: 1652–1655
De Maria R, Rippo MR, Schuchman EH, Testi R . 1998 J. Exp. Med. 187: 897–902
Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Jänicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K, Wesselborg S . 2000 Oncogene 19: 4563–4573
Farina F, Cappello F, Todaro M, Bucchieri F, Peri G, Zummo G, Stassi G . 2000 J. Histochem. Cytochem. 48: 57–62
Fujiwaki T, Hamanaka S, Koga M, Ishihara T, Nishikomori R, Kinoshita E, Furusho K . 1992 Acta Paediatr. Jpn. 34: 72–79
Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E . 2001 J. Biol. Chem. 276: 20589–20596
Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman, Green D . 1995 Immunity 2: 341–351
Gulbins E, Jekle A, Ferlinz K, Grassme H, Lang F . 2000 Am. J. Physiol. Renal. Physiol. 279: F605–F615
Hannun YA . 1996 Science 274: 1855–1859
Hofmann K, Dixit VM . 1998 Trends Biochem. Sci. 23: 374–377
Holopainen JM, Subramanian M, Kinnunen PK . 1998 Biochemistry 37: 17562–17570
Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL, Schuchman EH . 1995 Nat. Genet. 10: 288–293
Hsu SC, Wu CC, Luh TY, Chou CK, Han SH, Lai MZ . 1998 Blood 91: 2658–2663
Jänicke RU, Ng P, Sprengart ML, Porter AG . 1998 J. Biol. Chem. 273: 15540–15545
Kirschnek S, Paris F, Weller M, Grassme H, Ferlinz K, Riehle A, Fuks Z, Kolesnick R, Gulbins E . 2000 J. Biol. Chem. 275: 27316–27323
Koch J, Gartner S, Li CM, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman EH., Sandhoff K . 1996 J. Biol. Chem. 271: 33110–33115
Kolesnick RN, Krönke M . 1998 Annu. Rev. Physiol. 60: 643–665
Kolodny EH . 2000 Curr. Opin. Hematol. 7: 48–52
Levade T, Jaffrezou JP . 1999 Biochim. Biophys. Acta 1438: 1–17
Lin T, Genestier L, Pinkoski MJ, Castro A, Nicholas S, Mogil R, Paris F, Fuks Z, Schuchman EH, Kolesnick RN, Green DR . 2000 J. Biol. Chem. 275: 8657–8663
Liu P, Anderson RG . 1995 J. Biol. Chem. 270: 27179–27185
Los M, Wesselborg S, Schulze-Osthoff K . 1999 Immunity 10: 629–639
Los M, Neubüser D, Coy JF, Mozoluk M, Poustka A, Schulze-Osthoff K . 2000 Biochemistry 39: 7365–7373
Moser HW, Prensky AL, Wolfe HJ, Rosman NP . 1969 Am. J. Med. 47: 869–890
Nishioka K, Hasunuma T, Kato T, Sumida T, Kobata T . 1998 Arthritis Rheum. 41: 1–9
Obeid LM, Linardic CM, Karolak LA, Hannun YA . 1993 Science 259: 1769–1771
Otterbach B, Stoffel W . 1995 Cell 81: 1053–1061
Qualman SJ, Moser HW, Valle D, Moser AE, Antonarakis SE, Boitnott JK, Zinkham WH . 1987 Am. J. Med. Genet. Suppl. 3: 233–241
Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, Testi R . 2000 FASEB J. 14: 2047–2054
Scaffidi C, Medema JP, Krammer PH, Peter ME . 1997 J. Biol. Chem. 272: 26953–26958
Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I . 1998 J. Biol. Chem. 273: 18250–18259
Segui B, Bezombes C, Uro-Coste E, Medin JA, Andrieu-Abadie N, Auge N, Brouchet A, Laurent G, Salvayre R, Jaffrezou JP, Levade T . 2000 FASEB J. 14: 36–47
Spinedi A, Di Bartolomeo S, Piacentini M . 1999 Biochem. Biophys. Res. Commun. 255: 456–459
Strelow A, Bernardo K, Adam-Klages S, Linke T, Sandhoff K, Krönke M, Adam D . 2000 J. Exp. Med. 192: 601–612
Sugita M, Dulaney JT, Moser HW . 1972 Science 178: 1100–1102
Sugita M, Willians M, Dulaney JT, Moser HW . 1975 Biochim. Biophys. Acta 398: 125–131
Tang D, Lahti JM, Kidd VJ . 2000 J. Biol. Chem. 275: 9303–9307
Tepper AD, Cock JG, de Vries E, Borst J, van Blitterswijk WJ . 1997 J. Biol. Chem. 272: 24308–24312
Tepper AD, de Vries E, van Blitterswijk WJ., Borst J . 1999 J. Clin. Invest. 103: 971–978
Testi R . 1996 Trends Biochem. Sci. 21: 468–471
Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K . 1999 Blood 93: 3053–3063
Zundel W, Swiersz LM, Giaccia A . 2000 Mol. Cell. Biol. 20: 1507–1514
Acknowledgements
This work was supported by grants from the Interdisciplinary Center of Clinical Research (IZKF) of the University of Münster, the Deutsche Krebshilfe, the Deutsche Forschungsgemeinschaft (SFB 293) and the German Federal Ministry of Education and Research with the German-Israeli Project Cooperation (DIP).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burek, C., Roth, J., Koch, HG. et al. The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene 20, 6493–6502 (2001). https://doi.org/10.1038/sj.onc.1204841
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204841
Keywords
This article is cited by
-
Farber disease: clinical presentation, pathogenesis and a new approach to treatment
Pediatric Rheumatology (2007)
-
Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo
Oncogene (2007)
-
Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells
Oncogene (2005)
-
The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways
Oncogene (2003)